Stoke Therapeutics Inc. (STOK)
9.36
0.68 (7.83%)
At close: Jan 15, 2025, 11:15 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -2.21 | -3.86 | -10.4 | -40.98 | -17.84 | -48.01 | -58.82 |
| PS Ratio | 26.36 | 28.94 | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 1.45 | 1.94 | 4.05 | 7.25 | 2.27 | 5.72 | -253.03 |
| P/FCF Ratio | -2.8 | -10.02 | -12.94 | -47.93 | -15.57 | -50.52 | -59.47 |
| P/OCF Ratio | -2.85 | -11.27 | -13.17 | -49.12 | -16.39 | -54.83 | -60.72 |
| OCF/S Ratio | -9.23 | -2.57 | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | n/a | n/a | -2.32 |
| Quick Ratio | 6.99 | 7.43 | 13.37 | 25.73 | 55.12 | 43.03 | 0.51 |
| Current Ratio | 6.99 | 7.77 | 13.37 | 25.73 | 55.12 | 43.03 | 0.51 |
| Asset Turnover | 0.04 | 0.05 | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | -33.43 | -717.21 | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.66 | -0.5 | -0.39 | -0.18 | -0.13 | -0.12 | 4.30 |
| Return on Assets (ROA) | -0.46 | -0.36 | -0.35 | -0.17 | -0.12 | -0.12 | -2.28 |
| Return on Capital (ROIC) | -0.58 | -0.46 | -0.39 | -0.19 | -0.16 | -0.12 | 4.35 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 71.50% | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -1.19K% | -750.58% | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -1.19K% | -814.73% | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -1.31K% | -841.24% | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -941.72% | -288.82% | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -1.28K% | -828.78% | n/a | n/a | n/a | n/a | n/a |